Showing 1 - 8 results of 8 for search 'Vimal H. Prajapati, MD', query time: 0.05s Refine Results
  1. 1
    The burden of palmoplantar pustulosis: A Canadian population-based study of inpatient care, emergency departments, and outpatient clinicsCapsule Summary

    The burden of palmoplantar pustulosis: A Canadian population-based study of inpatient care, emergency departments, and outpatient clinicsCapsule Summary by Jean-Eric Tarride, MA, PhD, Vimal H. Prajapati, MD, Charles Lynde, MD, Gord Blackhouse, MA, MBA

    Published 2023
    Loading…
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    The burden associated with generalized pustular psoriasis: A Canadian population-based study of inpatient care, emergency departments, and hospital- or community-based outpatient clinicsCapsule Summary

    The burden associated with generalized pustular psoriasis: A Canadian population-based study of inpatient care, emergency departments, and hospital- or community-based outpatient c... by Jean-Eric Tarride, MA, PhD, Vimal H. Prajapati, MD, Charles Lynde, MD, Gord Blackhouse, MA, MBA

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review

    Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review by Abrahim Abduelmula, BScN, Asfandyar Mufti, MD, Derrick H.Y. Chong, BSc, Siddhartha Sood, HBSc, Vimal H. Prajapati, MD, Jensen Yeung, MD

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

    Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective ch... by Ronald Vender, MD, Irina Turchin, MD, Perla Lansang, MD, Vimal H. Prajapati, MD, Mark Legault, PhD, Maxime Barakat, MD, PhD, MBA, Jensen Yeung, MD

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Methotrexate-induced cutaneous ulceration and necrosis in chronic atopic dermatitis

    Methotrexate-induced cutaneous ulceration and necrosis in chronic atopic dermatitis by Malika A. Ladha, MD, Bryn Edgerton, BSc (Hons), Jonathan Levy, MD, Muhammad N. Mahmood, MD, Alim R. Devani, MD, Parbeer S. Grewal, MD, Vimal H. Prajapati, MD

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review

    Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review by Siddhartha Sood, HBSc, Ahmed Bagit, BSc, Martin Heung, Khalad Maliyar, MD, Abrahim Abduelmula, MD, Muskaan Sachdeva, MD, Jorge R. Georgakopoulos, MD, Asfandyar Mufti, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class

    Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the... by Ahmed Bagit, BSc, Khalad Maliyar, MD, Jorge R. Georgakopoulos, MD, Brian Rankin, BSc, Alexander Rimke, MSc, Asfandyar Mufti, MD, Heather Le, CRC, Ronald Vender, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study

    Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study by Yuliya Lytvyn, PhD, Asfandyar Mufti, MD, Hiba Zaaroura, MD, Muskaan Sachdeva, BHSc, Justin D. Lu, MSc, Brian D. Rankin, PhD, Vimal H. Prajapati, MD, Ronald Vender, MD, Jensen Yeung, MD, FRCPC

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: